This review explores various aspects of the HCC TME, including both cellular and non-
cellular components, to elucidate their roles in tumor development and progression …

Transcriptome complexity is emerging as an unprecedented and fascinating domain,
especially by high-throughput sequencing technologies that have unveiled a plethora of …

Background: Hepatocellular carcinoma (HCC) accounts for more than 75% of primary liver
cancers, which are the second leading cause of cancer-related deaths. The GALAD (gender …

Thalassemia is a heterogeneous congenital hemoglobinopathy common in the
Mediterranean region, Middle East, Indian subcontinent, and Southeast Asia with increasing …

GALAD outperforms aMAP and ALBI for predicting HCC in patien... : Hepatology Communications
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced …

Healthcare has undergone a revolutionary shift with the advent of smart technologies, and
smart toilets (STs) are among the innovative inventions offering non‐invasive continuous …

Introduction PTEN often mutates in tumors, and its manipulation is suggested to be used in
the development of preclinical tools in cancer research. This study aims to explore the …

Programmed cell death (PCD) is thought to have multiple roles in tumors. Here, the roles of
PCD-related genes were comprehensively analyzed to evaluate their values in …

Background: The aim of the present study was to develop an improved diagnostic and
prognostic model for HBV-associated HCC by combining AFP with PIVKA-II and other …

BACKGROUND Liver transplantation (LT) for hepatocellular carcinoma (HCC) has been
widely researched and is well established worldwide. The cornerstone of this treatment lies …